Radio/Pathological Evaluation of Tongue Cancer Infiltration (RaP E ToC)

March 26, 2021 updated by: Hospices Civils de Lyon

An Evaluation of the Radio/Pathological Correlation of Depth Of Invasion for Oral Squamous Cell Carcinoma, a Retrospective Study in a University Hospital in Lyon

The aim of the study is to assess the good correlation and prediction of the DOI for the post-operative pathological results and prognosis.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The population will include all the patients chirurgically treated for an OSCC for 2014 to 2019, who have a pre operativ scanner at least in their medical file.

We will exclude the T4, the patients with very artefacted exams, and those with R+ resections.

Description

Inclusion Criteria:

  • patients chirurgically treated for an OSCC
  • T1 T2 T3
  • CT scanner in their medical file

Exclusion Criteria:

  • T4
  • R+ résection
  • Artefacts on CT scanner

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients who improved surgical treatment for oral cavity cancer
T1 T2 and T3 OSCC tumor, patients who have a recent evaluation cervico thoracic scanner in their medical files.

We will analyse the pre operative scannographic and MRI (if available) images, and the post operative pathological analyses.

The scanners will be reviewed by 2 well trained clinicians (one head and neck radiologist and one head and neck surgeon).

Then we will analyse the correlation between the radiological and the pathological analysis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The primary outcome will be the measure of the correlation of the depth of invasion on the radiological pre operative images and of the pathological analyses on the resection piece.
Time Frame: The outcome will be measured at the inclusion of the patient in the current study.
With a Bland Altman analysis we will assess the good correlation between the pre and post operatory mesures of the depth of invasion in the oral squamous cell carcioma
The outcome will be measured at the inclusion of the patient in the current study.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 27, 2020

Primary Completion (Actual)

November 27, 2020

Study Completion (Anticipated)

May 27, 2021

Study Registration Dates

First Submitted

March 25, 2021

First Submitted That Met QC Criteria

March 26, 2021

First Posted (Actual)

March 29, 2021

Study Record Updates

Last Update Posted (Actual)

March 29, 2021

Last Update Submitted That Met QC Criteria

March 26, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cell Carcinoma

Clinical Trials on Radiologic and pathological review.

Subscribe